WHOOP has closed a massive $575 million Series G funding round, valuing the wearable health company at $10.1 billion. The Boston-based startup attracted an impressive list of backers, from healthcare giant Abbott to sports superstars Cristiano Ronaldo and LeBron James.
The round was led by Collaborative Fund, with participation from sovereign wealth funds Qatar Investment Authority and Mubadala Investment Company. Healthcare heavyweight Mayo Clinic also joined the round, alongside a roster of elite athletes including Rory McIlroy, Reggie Miller, and Virgil van Dijk.
The money will be used for…
WHOOP plans to accelerate its international expansion across Europe, the Gulf states, Latin America, and Asia. The company currently ships to 56 countries but sees major growth opportunities in new markets.
The funding will also help WHOOP build what it calls “the world’s leading personal health platform.” This includes:
- Expanding its AI-powered health insights using data from over 24 billion hours of physiological monitoring
- Developing new features for disease prevention and early warning systems
- Scaling its platform to handle millions more users globally
Why does it matter?
WHOOP is betting big on a shift from reactive to preventive healthcare. The company argues that rising chronic disease rates and strained healthcare systems create an opportunity for continuous health monitoring that can predict problems before they happen.
The engagement numbers suggest users are buying into this vision. WHOOP members check the app over eight times per day – nearly three times more than users of other screenless wearables. The device tracks sleep, recovery, strain, and fitness while providing personalized recommendations.
Abbott’s involvement as a strategic investor is particularly significant. The healthcare giant brings deep expertise in diagnostics and medical devices, plus a track record in health tech innovation. This partnership could help WHOOP expand beyond fitness tracking into serious medical applications.
The context
WHOOP has been building toward this moment for over a decade since its 2012 founding. The company has now raised more than $900 million in total venture funding and claims millions of users worldwide.
The wearable market is increasingly crowded, with Apple dominating through its Watch and companies like Oura competing in the ring form factor. But WHOOP has carved out a niche among serious athletes and health-conscious professionals who want detailed biometric tracking.
Key differentiators include:
- A 14-day battery life that eliminates daily charging
- FDA-cleared ECG monitoring
- Advanced lab analysis for blood biomarkers
- Focus on actionable health insights rather than just data collection
“WHOOP has become one of the most important tools I use to support my long-term health,” said Cristiano Ronaldo, who serves as both an investor and global ambassador. “No other company has created a health platform this powerful that people are proud to wear.”